Skip to main content
NCBI home page
The Western Journal of Medicine logoLink to The Western Journal of Medicine
. 1977 May;126(5):347–352.

Subtypes of Depression—Diagnosis and Medical Management

Robert J Bielski 1, Robert O Friedel 1
PMCID: PMC1237582  PMID: 17227

Abstract

Depression is both a common and a greatly undertreated illness in the United States today. The focus of this review is a definition of the characteristics of four subtypes of depression which appear to be differentially sensitive to four different classes of medications. The tricyclic antidepressants should be used for patients with unipolar depression and vegetative symptoms. Lithium appears to be most effective for bipolar depressives. The monoamine oxidase (MAO) inhibitors are best used for patients with atypical depression. Antipsychotic medications appear to be useful for depressed patients with psychotic symptoms or agitation. Recent pharmacokinetic and biochemical data, including serum lithium levels, plasma tricyclic levels, and the predictive ability of pretreatment urinary 3-methoxy-4-hydroxyphenylglycol (MHPG) levels are also reviewed.

Full text

PDF
347

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BETHUNE H. C., BURRELL R. H., CULPAN R. H., OGG G. J. VASCULAR CRISES ASSOCIATED WITH MONOAMINE-OXIDASE INHIBITORS. Am J Psychiatry. 1964 Sep;121:245–248. doi: 10.1176/ajp.121.3.245. [DOI] [PubMed] [Google Scholar]
  2. BURT C. G., GORDON W. F., HOLT N. F., HORDERN A. Amitriptyline in depressive states:a controlled trial. J Ment Sci. 1962 Sep;108:711–730. doi: 10.1192/bjp.108.456.711. [DOI] [PubMed] [Google Scholar]
  3. Baron M., Gershon E. S., Rudy V., Jonas W. Z., Buchsbaum M. Lithium carbonate response in depression. Prediction by unipolar/bipolar illness, average-evoked response, catechol-O-methyl transferase, and family history. Arch Gen Psychiatry. 1975 Sep;32(9):1107–1111. doi: 10.1001/archpsyc.1975.01760270039003. [DOI] [PubMed] [Google Scholar]
  4. Beckmann H., Goodwin F. K. Antidepressant response to tricyclics and urinary MHPG in unipolar patients. Clinical response to imipramine or amitriptyline. Arch Gen Psychiatry. 1975 Jan;32(1):17–21. doi: 10.1001/archpsyc.1975.01760190019001. [DOI] [PubMed] [Google Scholar]
  5. Bielski R. J., Friedel R. O. Prediction of tricyclic antidepressant response: a critical review. Arch Gen Psychiatry. 1976 Dec;33(12):1479–1489. doi: 10.1001/archpsyc.1976.01770120083009. [DOI] [PubMed] [Google Scholar]
  6. Braithwaite R. A., Goulding R., Theano G., Bailey J., Coppen A. Plasma concentration of amitriptyline and clinical response. Lancet. 1972 Jun 17;1(7764):1297–1300. doi: 10.1016/s0140-6736(72)91031-8. [DOI] [PubMed] [Google Scholar]
  7. Cooper T. B., Bergner P. E., Simpson G. M. The 24-hour serum lithium level as a prognosticator of dosage requirements. Am J Psychiatry. 1973 May;130(5):601–603. doi: 10.1176/ajp.130.5.601. [DOI] [PubMed] [Google Scholar]
  8. DALLY P. J., ROHDE P. Comparison of antidepressant drugs in depressive illnesses. Lancet. 1961 Jan 7;1(7167):18–20. doi: 10.1016/s0140-6736(61)92186-9. [DOI] [PubMed] [Google Scholar]
  9. Davis J. M. Overview: maintenance therapy in psychiatry: II. Affective disorders. Am J Psychiatry. 1976 Jan;133(1):1–13. doi: 10.1176/ajp.133.1.1. [DOI] [PubMed] [Google Scholar]
  10. Detre T., Himmelhoch J., Swartzburg M., Anderson C. M., Byck R., Kupfer D. J. Hypersomnia and manic-depressive disease. Am J Psychiatry. 1972 Apr;128(10):1303–1305. doi: 10.1176/ajp.128.10.1303. [DOI] [PubMed] [Google Scholar]
  11. Deykin E. Y., DiMascio A. Relationship of patient background characteristics to efficacy of pharmacotherapy in depression. J Nerv Ment Dis. 1972 Sep;155(3):209–215. doi: 10.1097/00005053-197209000-00008. [DOI] [PubMed] [Google Scholar]
  12. Downing R. W., Rickels K. Predictors of amitriptyline response in outpatient depressives. J Nerv Ment Dis. 1972 Apr;154(4):248–263. doi: 10.1097/00005053-197204000-00003. [DOI] [PubMed] [Google Scholar]
  13. Downing R. W., Rickels K. Predictors of response to amitriptyline and placebo in three outpatient treatment settings. J Nerv Ment Dis. 1973 Feb;156(2):109–129. doi: 10.1097/00005053-197302000-00004. [DOI] [PubMed] [Google Scholar]
  14. Dunner D. L., Stallone F., Fieve R. R. Lithium carbonate and affective disorders. V: A double-blind study of prophylaxis of depression in bipolar illness. Arch Gen Psychiatry. 1976 Jan;33(1):117–120. doi: 10.1001/archpsyc.1976.01770010073014. [DOI] [PubMed] [Google Scholar]
  15. FRIEDMAN C., DE MOWBRAY M. S., HAMILTON V. Imipramine (Tofranil) in depressive states: a controlled trial with inpatients. J Ment Sci. 1961 Sep;107:948–953. doi: 10.1192/bjp.107.450.948. [DOI] [PubMed] [Google Scholar]
  16. Fawcett J., Maas J. W. Depression and MHPG excretion. Response to dextroamphetamine and tricyclic antidepressants. Arch Gen Psychiatry. 1972 Mar;26(3):246–251. doi: 10.1001/archpsyc.1972.01750210054011. [DOI] [PubMed] [Google Scholar]
  17. Fieve R. R., Dunner D. L., Kumbarachi T., Stallone F. Lithium carbonate in affective disorders. IV. A double-blind study of prophylaxis in unipolar recurrent depression. Arch Gen Psychiatry. 1975 Dec;32(12):1541–1544. doi: 10.1001/archpsyc.1975.01760300079006. [DOI] [PubMed] [Google Scholar]
  18. Fieve R. R., Platman S. R., Plutchik R. R. The use of lithium in affective disorders. I. Acute endogenous depression. Am J Psychiatry. 1968 Oct;125(4):487–491. doi: 10.1176/ajp.125.4.487. [DOI] [PubMed] [Google Scholar]
  19. Galambos M. Letter: Energizing effects of piperacetazine. Am J Psychiatry. 1975 Dec;132(12):1333–1334. doi: 10.1176/ajp.132.12.aj132121333. [DOI] [PubMed] [Google Scholar]
  20. Glassman A. H., Kantor S. J., Shostak M. Depression, Delusions, and Drug Response. Am J Psychiatry. 1975 Jul;132(7):716–719. doi: 10.1176/ajp.132.7.716. [DOI] [PubMed] [Google Scholar]
  21. Glassman A. H., Perel J. M., Shostak M., Kantor S. J., Fleiss J. L. Clinical implications of imipramine plasma levels for depressive illness. Arch Gen Psychiatry. 1977 Feb;34(2):197–204. doi: 10.1001/archpsyc.1977.01770140087010. [DOI] [PubMed] [Google Scholar]
  22. Goodwin F. K., Murphy D. L., Bunney W. E., Jr Lithium-carbonate treatment in depression and mania. A longitudinal double-blind study. Arch Gen Psychiatry. 1969 Oct;21(4):486–496. doi: 10.1001/archpsyc.1969.01740220102012. [DOI] [PubMed] [Google Scholar]
  23. Goodwin F. K., Murphy D. L., Dunner D. L., Bunney W. E., Jr Lithium response in unipolar versus bipolar depression. Am J Psychiatry. 1972 Jul;129(1):44–47. doi: 10.1176/ajp.129.1.44. [DOI] [PubMed] [Google Scholar]
  24. Gram L. F., Reisby N., Ibsen I., Nagy A., Dencker S. J., Bech P., Petersen G. O., Christiansen J. Plasma levels and antidepressive effect of imipramine. Clin Pharmacol Ther. 1976 Mar;19(3):318–324. doi: 10.1002/cpt1976193318. [DOI] [PubMed] [Google Scholar]
  25. HORDERN A., HOLT N. F., BURT C. G., GORDON W. F. AMITRIPTYLINE IN DEPRESSIVE STATES: PHENOMENOLOGY AND PROGNOSTIC CONSIDERATIONS. Br J Psychiatry. 1963 Nov;109:815–825. doi: 10.1192/bjp.109.463.815. [DOI] [PubMed] [Google Scholar]
  26. Himmelhoch J. M., Detre T., Kupfer D. J., Swartzburg M., Byck R. Treatment of previously intractable depressions with tranylcypromine and lithium. J Nerv Ment Dis. 1972 Sep;155(3):216–220. doi: 10.1097/00005053-197209000-00009. [DOI] [PubMed] [Google Scholar]
  27. Hollister L. E., Overall J. E. Reflections on the specificity of action of anti-depressants. Psychosomatics. 1965 Sep-Oct;6(5):361–365. doi: 10.1016/s0033-3182(65)72257-3. [DOI] [PubMed] [Google Scholar]
  28. Johnson G. Antidepressant effect of lithium. Compr Psychiatry. 1974 Jan-Feb;15(1):43–47. doi: 10.1016/0010-440x(74)90063-7. [DOI] [PubMed] [Google Scholar]
  29. Johnson W. C. A neglected modality in psychiatric treatment--the monoamine oxidase inhibitors. Dis Nerv Syst. 1975 Sep;36(9):521–525. [PubMed] [Google Scholar]
  30. Ketai R. Family practitioners' knowledge about treatment of depressive illness. JAMA. 1976 Jun 14;235(24):2600–2603. [PubMed] [Google Scholar]
  31. Kiloh L. G., Ball J. R., Garside R. F. Prognostic Factors in Treatment of Depressive States with Imipramine. Br Med J. 1962 May 5;1(5287):1225–1227. doi: 10.1136/bmj.1.5287.1225. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Klein D. F. Endogenomorphic depression. A conceptual and terminological revision. Arch Gen Psychiatry. 1974 Oct;31(4):447–454. doi: 10.1001/archpsyc.1974.01760160005001. [DOI] [PubMed] [Google Scholar]
  33. Kline N. S. Antidepressant medications. A more effective use by general practitioners, family physicians, internists, and others. JAMA. 1974 Mar 11;227(10):1158–1160. doi: 10.1001/jama.227.10.1158. [DOI] [PubMed] [Google Scholar]
  34. Kragh-Sorensen P., Hansen C. E., Asberg M. Plasma levels of nortriptyline in the treatment of endogenous depression. Acta Psychiatr Scand. 1973;49(4):444–456. doi: 10.1111/j.1600-0447.1973.tb04437.x. [DOI] [PubMed] [Google Scholar]
  35. Kupfer D. J., Foster F. G., Reich L., Thompson S. K., Weiss B. EEG sleep changes as predictors in depression. Am J Psychiatry. 1976 Jun;133(6):622–626. doi: 10.1176/ajp.133.6.622. [DOI] [PubMed] [Google Scholar]
  36. Kupfer D. J., Pickar D., Himmelhoch J. M., Detre T. P. Are there two types of unipolar depression? Arch Gen Psychiatry. 1975 Jul;32(7):866–871. doi: 10.1001/archpsyc.1975.01760250058006. [DOI] [PubMed] [Google Scholar]
  37. Lingjaerde O., Edlund A. H., Gormsen C. A., Gottfries C. G., Haugstad A., Hermann I. L., Hollnagel P., Mäkimattilla A., Rasmussen K. E., Remvig J. The effects of lithium carbonate in combination with tricyclic antidepressants in endogenous depression. A double-blind, multicenter trial. Acta Psychiatr Scand. 1974;50(2):233–242. doi: 10.1111/j.1600-0447.1974.tb08212.x. [DOI] [PubMed] [Google Scholar]
  38. Maas J. W. Biogenic amines and depression. Biochemical and pharmacological separation of two types of depression. Arch Gen Psychiatry. 1975 Nov;32(11):1357–1361. doi: 10.1001/archpsyc.1975.01760290025002. [DOI] [PubMed] [Google Scholar]
  39. Maas J. W., Fawcett J. A., Dekirmenjian H. Catecholamine metabolism, depressive illness, and drug response. Arch Gen Psychiatry. 1972 Mar;26(3):252–262. doi: 10.1001/archpsyc.1972.01750210060012. [DOI] [PubMed] [Google Scholar]
  40. Mendels J. Lithium in the treatment of depression. Am J Psychiatry. 1976 Apr;133(4):373–378. doi: 10.1176/ajp.133.4.373. [DOI] [PubMed] [Google Scholar]
  41. Mendels J., Secunda S. K., Dyson W. L. A controlled study of the antidepressant effects of lithium carbonate. Arch Gen Psychiatry. 1972 Feb;26(2):154–157. doi: 10.1001/archpsyc.1972.01750200058012. [DOI] [PubMed] [Google Scholar]
  42. Noyes R., Jr, Dempsey G. M., Blum A., Cavanaugh G. L. Lithium treatment of depression. Compr Psychiatry. 1974 May-Jun;15(3):187–193. doi: 10.1016/0010-440x(74)90015-7. [DOI] [PubMed] [Google Scholar]
  43. Overall J. E., Hollister L. E., Johnson M., Pennington V. Nosology of depression and differential response to drugs. JAMA. 1966 Mar 14;195(11):946–948. [PubMed] [Google Scholar]
  44. Paykel E. S. Depressive typologies and response to amitriptyline. Br J Psychiatry. 1972 Feb;120(555):147–156. doi: 10.1192/bjp.120.555.147. [DOI] [PubMed] [Google Scholar]
  45. Paykel E. S., Prusoff B. A., Klerman G. L., Haskell D., DiMascio A. Clinical response to amitriptyline among depressed women. J Nerv Ment Dis. 1973 Mar;156(3):149–165. doi: 10.1097/00005053-197303000-00001. [DOI] [PubMed] [Google Scholar]
  46. Prien R. F., Caffey E. M., Jr, Klett C. J. Factors associated with treatment success in lithium carbonate prophylaxis. Report of the Veterans Administration and National Institute of Mental Health collaborative study group. Arch Gen Psychiatry. 1974 Aug;31(2):189–192. doi: 10.1001/archpsyc.1974.01760140041006. [DOI] [PubMed] [Google Scholar]
  47. Prien R. F., Caffey E. M., Jr Relationship between dosage and response to lithium prophylaxis in recurrent depression. Am J Psychiatry. 1976 May;133(5):567–570. doi: 10.1176/ajp.133.5.567. [DOI] [PubMed] [Google Scholar]
  48. Prien R. F., Klett C. J., Caffey E. M., Jr Lithium carbonate and imipramine in prevention of affective episodes. A comparison in recurrent affective illness. Arch Gen Psychiatry. 1973 Sep;29(3):420–425. doi: 10.1001/archpsyc.1973.04200030104017. [DOI] [PubMed] [Google Scholar]
  49. Prien R. F., Klett C. J., Caffey E. M., Jr Lithium prophylaxis in recurrent affective illness. Am J Psychiatry. 1974 Feb;131(2):198–203. doi: 10.1176/ajp.131.2.198. [DOI] [PubMed] [Google Scholar]
  50. Quitkin F., Rifkin A., Klein D. F. Prophylaxis of affective disorders. Current status of knowledge. Arch Gen Psychiatry. 1976 Mar;33(3):337–341. doi: 10.1001/archpsyc.1976.01770030051007. [DOI] [PubMed] [Google Scholar]
  51. RICKELS K., WARD C. H., SCHUT L. DIFFERENT POPULATIONS, DIFFERENT DRUG RESPONSES. A COMPARATIVE STUDY OF TWO ANTI-DEPRESSANTS, EACH USED IN TWO DIFFERENT PATIENT GROUPS. Am J Med Sci. 1964 Mar;247:328–335. doi: 10.1097/00000441-196403000-00013. [DOI] [PubMed] [Google Scholar]
  52. ROBIN A. A., LANGLEY G. E. A CONTROLLED TRIAL OF IMIPRAMINE. Br J Psychiatry. 1964 May;110:419–422. doi: 10.1192/bjp.110.466.419. [DOI] [PubMed] [Google Scholar]
  53. Raskin A. Adverse reactions to phenelzine: results of a nine-hospital depression study. J Clin Pharmacol New Drugs. 1972 Jan;12(1):22–25. doi: 10.1002/j.1552-4604.1972.tb00031.x. [DOI] [PubMed] [Google Scholar]
  54. Raskin A., Boothe H., Schulterbrandt J. G., Reatig N., Odle D. A model for drug use with depressed patients. J Nerv Ment Dis. 1973 Feb;156(2):130–142. doi: 10.1097/00005053-197302000-00005. [DOI] [PubMed] [Google Scholar]
  55. Raskin A., Crook T. H. The endogenous--neurotic distinction as a predictor of response to antidepressant drugs. Psychol Med. 1976 Feb;6(1):59–70. doi: 10.1017/s0033291700007509. [DOI] [PubMed] [Google Scholar]
  56. Raskin A., Schulterbrandt J. G., Reatig N., McKeon J. J. Differential response to chlorpromazine, imipramine, and placebo. A study of subgroups of hospitalized depressed patients. Arch Gen Psychiatry. 1970 Aug;23(2):164–173. doi: 10.1001/archpsyc.1970.01750020068009. [DOI] [PubMed] [Google Scholar]
  57. Robinson D. S., Nies A., Ravaris C. L., Lamborn K. R. The monoamine oxidase inhibitor, phenelzine, in the treatment of depressive -anxiety states. A controlled clinical trial. Arch Gen Psychiatry. 1973 Sep;29(3):407–413. doi: 10.1001/archpsyc.1973.04200030093015. [DOI] [PubMed] [Google Scholar]
  58. SARGANT W. The treatment of anxiety states and atypical depressions by the monoamine oxidase inhibitor drugs. J Neuropsychiatr. 1962 Aug;3(Suppl 1):S–103. [PubMed] [Google Scholar]
  59. Sargant W. Drugs in the Treatment of Depression. Br Med J. 1961 Jan 28;1(5221):225–227. doi: 10.1136/bmj.1.5221.225. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Schildkraut J. J. Norepinephrine metabolites as biochemical criteria for classifying depressive disorders and predicting responses to treatment: preliminary findings. Am J Psychiatry. 1973 Jun;130(6):695–699. doi: 10.1176/ajp.130.6.695. [DOI] [PubMed] [Google Scholar]
  61. Schuckit M., Robins E., Feighner J. Tricyclic antidepressants and monoamine oxidase inhibitors. Arch Gen Psychiatry. 1971 Jun;24(6):509–514. doi: 10.1001/archpsyc.1971.01750120025005. [DOI] [PubMed] [Google Scholar]
  62. Tyrer P. Towards rational therapy with monoamine oxidase inhibitors. Br J Psychiatry. 1976 Apr;128:354–360. doi: 10.1192/bjp.128.4.354. [DOI] [PubMed] [Google Scholar]
  63. WEST E. D., DALLY P. J. Effects of iproniazid in depressive syndromes. Br Med J. 1959 Jun 13;1(5136):1491–1494. doi: 10.1136/bmj.1.5136.1491. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Watanabe S., Ishino H., Otsuki S. Double-blind comparison of lithium carbonate and imipramine in treatment of depression. Arch Gen Psychiatry. 1975 May;32(5):659–668. doi: 10.1001/archpsyc.1975.01760230125010. [DOI] [PubMed] [Google Scholar]
  65. Winston F. Combined antidepressant therapy. Br J Psychiatry. 1971 Mar;118(544):301–304. doi: 10.1192/bjp.118.544.301. [DOI] [PubMed] [Google Scholar]
  66. Wittenborn J. R., Kiremitci N., Weber E. S. The choice of alternative antidepressants. J Nerv Ment Dis. 1973 Feb;156(2):97–108. doi: 10.1097/00005053-197302000-00003. [DOI] [PubMed] [Google Scholar]
  67. Zall H., Therman P. G., Myers J. M. Lithium carbonate: a clinical study. Am J Psychiatry. 1968 Oct;125(4):549–555. doi: 10.1176/ajp.125.4.549. [DOI] [PubMed] [Google Scholar]

Articles from Western Journal of Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES